scholarly journals Effect of short‑term testosterone replacement therapy on heart rate variability in men with hypoandrogen‑metabolic syndrome

2013 ◽  
Vol 123 (9) ◽  
pp. 467-473 ◽  
Author(s):  
Adam R. Poliwczak ◽  
Maja Tylińska ◽  
Marlena Broncel
Keyword(s):  
Metabolic Syndrome ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Replacement Therapy ◽  
Testosterone Replacement ◽  
Testosterone Replacement Therapy ◽  
Short Term

scholarly journals Metabolic syndrome and short-term heart rate variability in young adults

2009 ◽  
Vol 26 (4) ◽  
pp. 354-361 ◽  
Author(s):  
T. Koskinen ◽  
M. Kähönen ◽  
A. Jula ◽  
N. Mattsson ◽  
T. Laitinen ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Young Adults ◽  
Short Term

scholarly journals Short term testosterone replacement therapy improves libido and body composition

2009 ◽  
Vol 53 (8) ◽  
pp. 996-1004 ◽  
Author(s):  
Edésio Seara de Andrade Júnior ◽  
Ruth Clapauch ◽  
Salo Buksman
Keyword(s):  
Body Composition ◽  
Waist Circumference ◽  
Replacement Therapy ◽  
Late Onset ◽  
Testosterone Replacement ◽  
Testosterone Replacement Therapy ◽  
Efficacy And Safety ◽  
Short Term ◽  
Sf 36 ◽  
Late Onset Hypogonadism

OBJECTIVE: To assess the efficacy and safety of testosterone replacement in males with late-onset hypogonadism compared to hypogonadal men without replacement, and controls, during six months. METHODS: We assessed, through ADAM, AMS, IIEF-5 and SF-36 questionnaires, and through clinical and laboratorial examinations, 62 patients divided into three groups: 17 hypogonadal males (HR) used intramuscular testosterone every three weeks; 14 hypogonadal males (HV) and 31 non-hypogonadal males (CV) used oral vitamins daily. RESULTS: When compared to others, HR group obtained libido improvement assessed by ADAM 1 (p = 0.004), and borderline sexual potency improvement assessed by IIEF-5 (p = 0.053), besides a decrease in waist circumference after eight weeks (p = 0.018). The remaining parameters did not differ between the groups. PSA and hematocrit remained stable in those using testosterone. CONCLUSION: Six months of testosterone replacement improved sexuality and body composition, with prostatic and hematological safety.

Testosterone Replacement Therapy and Components of the Metabolic Syndrome

2017 ◽  
Vol 5 (2) ◽  
pp. 200-210 ◽  
Author(s):  
James Anaissie ◽  
Natalie H. Roberts ◽  
Ping Wang ◽  
Faysal A. Yafi
Keyword(s):  
Metabolic Syndrome ◽  
Replacement Therapy ◽  
Testosterone Replacement ◽  
Testosterone Replacement Therapy ◽  
The Metabolic Syndrome

Prevalence of metabolic syndrome and testosterone replacement therapy in mans with andropause

Maturitas ◽  
2015 ◽  
Vol 81 (1) ◽  
pp. 212
Author(s):  
Sergey V. Nedogoda ◽  
Irina N. Barykina ◽  
Alla S. Salasyuk ◽  
Viktoria O. Smirnova ◽  
Ekaterina A. Popova
Keyword(s):  
Metabolic Syndrome ◽  
Replacement Therapy ◽  
Testosterone Replacement ◽  
Testosterone Replacement Therapy
Sign in / Sign up

Export Citation Format

Share Document